NFE2L2 and malignant colon neoplasm: In human colon cancer cells, HT-29, luteolin promotes DNA demethylation of the NRF2 promoter, inhibits the expression of DNA methyltransferases, and increases the levels and activity of ten-eleven translocation (TET).